Your browser doesn't support javascript.
loading
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Liang, Guanghao; Wang, Linchen; You, Qiancheng; Cahill, Kirk; Chen, Chuanyuan; Zhang, Wei; Fulton, Noreen; Stock, Wendy; Odenike, Olatoyosi; He, Chuan; Han, Dali.
Afiliação
  • Liang G; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, 100101, China.
  • Wang L; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • You Q; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, 100101, China.
  • Cahill K; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Chen C; Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, 60637, USA.
  • Zhang W; Howard Hughes Medical Institute, Chicago, IL, 60637, USA.
  • Fulton N; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL, 60637, USA.
  • Stock W; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, 100101, China.
  • Odenike O; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • He C; Department of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.
  • Han D; Bristol-Myers Squibb, San Diego, CA, 92121, USA.
Adv Sci (Weinh) ; 10(23): e2300445, 2023 08.
Article em En | MEDLINE | ID: mdl-37271891

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha